2′,4′-Dihydroxychalcone-induced apoptosis of human gastric cancer MGC-803 cells via down-regulation of survivin mRNA

Toxicology in Vitro

Volumn 24, Issue 5, 2010, Pages 1333-1337

  Lou, Chenghua ^a,b   Yang, Guangming ^b   Cai, Hao ^b   Zou, Mingchang ^b   Xu, Zisheng ^a,b   Li, Yu ^b   Zhao, Fengming ^b   Li, Weidong ^b   Tong, Li ^c   Wang, Mingyan ^b   Cai, Baochang ^a,b  

^a Nanjing Haichang Chinese Medicine Group Corporation   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c QINGHAI UNIVERSITY   (China)

Author keywords

2 ,4 Dihydroxychalcone; Apoptosis; Herba oxytropis; MGC 803 cells; Survivin

Indexed keywords

2',4' DIHYDROXYCHALCONE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CASPASE 3; CHALCONE DERIVATIVE; MESSENGER RNA; SURVIVIN; UNCLASSIFIED DRUG; 2',4'-DIHYDROXYCHALCONE; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SHAPE; CELL SURVIVAL; CHEMICAL STRUCTURE; CONCENTRATION PROCESS; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HERBA OXYTROPIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEGUME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; CELL CYCLE; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TIBETAN MEDICINE; TUMOR CELL LINE;

OXYTROPIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CHALCONES; DOWN-REGULATION; HUMANS; MEDICINE, TIBETAN TRADITIONAL; MICROTUBULE-ASSOCIATED PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 77953609639     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.05.003     Document Type: Article

References (31)

1. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine 1997, 3:917-921.
2. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annual Review of Cell and Developmental Biology 1999, 15:269-290.
3. Chen J.J., Lee H.H., Duh C.Y., Chen I.S. Cytotoxic chalcones and flavonoids from the leaves of Muntingia calabura. Planta Medica 2005, 71(10):970-973.
4. Dimmock J.R., Elias D.W., Beazely M.A., Kandepu N.M. Bioactivities of chalcones. Current Medicinal Chemistry 1999, 6:1125-1149.
5. Go M.L., Wu X., Liu X.L. Chalcones: an update on cytotoxic and chemoprotective properties. Current Medicinal Chemistry 2005, 12:481-499.
6. Hsu Y.L., Kuo P.L., Tzeng W.S., Lin C.C. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food and Chemical Toxicology 2006, 44:704-713.
7. Iwata S., Nishino T., Nagata N., Satomi Y., Nishino H., Shibata S. Antitumorigenic activities of chalcones. I. Inhibitory effects of chalcone derivatives on 32Pi-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoyl-phorbol 13-acetate (TPA). Biological & Pharmaceutical Bulletin 1995, 18(12):1710-1713.
8. Jiang H., Hu J.R., Liu X. A researching review about Oxytropis falcate Bunge. Chinese Traditional and Herbal Drugs 2006, 37:314-315.
9. Kachadourian R., Day B.J. Flavonoid-induced glutathione depletion: Potential implications for cancer treatment. Free Radical Biology & Medicine 2006, 41:65-76.
10. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Research 1998, 58:5071-5074.
11. Krepela E. Cysteine proteinases in tumor cell growth and apoptosis. Neoplasma 2001, 48:332-349.
12. Lei, J.F., Zhang, Y.S., Chen, L.J., Liu, H.L., He, G.J., 2008. Faming Zhuanli Shenqing Gongkai Shuomingshu CN 101181372.
13. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584.
14. Liu Y.C., Hsieh C.W., Wu C.C., Wung B.S. Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophile. Life Sciences 2007, 80:1420-1430.
15. Lou C.H., Wang M.Y., Yang G.M., Cai H., Li Y., Zhao F.M., Yang H., Tong L., Cai B.C. Preliminary studies on anti-tumor activity of 2, 4-dihydroxychalcone isolated from Tibetan medicine Herba Oxytropis in human gastric cancer MGC-803 cells. Toxicology In Vitro 2009, 23:906-910.
16. Lu C.D., Altieri D.C., Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Research 1998, 58:1808-1812.
17. Luo D.S. China Traditional Tibetan Herbal 1997, Nation Press, Beijing, (p. 139).
18. Mao J.Z., Luo D.S., Wang Z.H. Jing Zhu herbal, Shanghai Science and Technology Press. Shanghai 1986, 111-112:181.
19. Monzo M., Rosell R., Felip E., Astudillo J., Sanchez J.J., Maestre J., Martin C., Font A., Barnadas A., Abad A. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. Journal of Clinical Oncology 1999, 17:2100-2104.
20. Pouget C., Lauthier F., Simon A., Fagnere C., Basly J.P., Delage C., Chulia A.J. Flavonoids: Structural requirements for antiproliferative activity on breast cancer cells. Bioorganic and Medicinal Chemistry Letters 2001, 11:3095-3097.
21. Ramonede B.M., Tomas R.P. Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosin. Biochemical Pharmacology 2002, 63:463-469.
22. Ryan B., O'Donovan N., Browne B., O'Shea C., Crown J., Hill A.D.K., McDermott E., O'Higgins N., Duffy M.J. Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer. British Journal of Cancer 2005, 92:120-124.
23. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001, 40:1117-1123.
24. Stoner G.D., Mukhtar H. Polyphenols as cancer chemopreventive agents. Journal of Cellular Biochemistry Supplement 1995, 22:169-180.
25. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clinical Cancer Research 2000, 6:127-134.
26. Tong L., Yuan D.P., Li Y.W., Rezeng C.D., Wang H.J., Zhaxi D.Z. Experimental study on the anti-inflammatory, analgesic actions of Oxytropis falcate Bunge. Journal of Sichuan of Traditional Chinese Medicine 2008, 26:53-55.
27. Wang D., Yang H., Tong L., Cai B.C. Analgesic and anti-inflammatory activity of Tibetan medicine Oxytropis falcata. Pharmaceutical and Clinical Research 2008, 16:12-14.
28. Wei Q., He Y.P., Li J.C. The pharmacological effects of Oxytropis falcate Bunge on hypothalamo-pituitary-adrenocortical system. National Medical Journal of China 1979, 59:677-679.
29. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annual Review of Nutrition 2001, 21:381-406.
30. Yang H., Wang D., Tong L., Cai B.C. Studies on chemical constituents of Oxytropis falcata (I). Chinese Pharmaceutical Journal 2008, 43(5):338-340.
31. Yin W., Jiang G., Takeyasu K., Zhou X. Stimulation of Na, K-ATPase by low potassium is dependent on transferrin. Journal of Membrane Biology 2003, 193:177-184.